AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 29, 2023

Indian healthcare providers and pharma companies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69

Pharma Companies 178

Pharma Companies Drugs Medicine Research 178

Pharmaceutical Technology

MAY 28, 2024

Logistics service providers (LSPs) can help pharma companies achieve their supply chain goals

Pharma Companies 130

Pharma Companies 130

pharmaphorum

JUNE 13, 2024

Learn valuable marketing lessons for B2B pharma companies by examining successful strategies used in the B2C prescription market, including over-the-counter (OTC) products and interactions with healthcare professionals (HCPs).

Pharma Companies 116

Pharma Companies Marketing Production 116

Fierce Pharma

JULY 19, 2024

While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown | While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at (..)

Pharma Companies 123

Pharma Companies 123

Pharmaceutical Technology

JUNE 30, 2022

to acquire Turkish pharma company Gensenta for $135m appeared first on Pharmaceutical Technology. “This acquisition fuels our growth by adding local production capabilities in pharmaceuticals, biosimilar products, and active ingredients to our investment portfolio as well as export competency.”. The post Eczac?ba??

Pharma Companies 147

Pharma Companies Manufacturing Production Marketing 147

Bio Pharma Dive

NOVEMBER 19, 2020

The deal, which has Pfizer paying as much as $70 million, is the latest in a series of moves by big pharma companies to forge a stronger position in the world's second-largest drug market.

Pharma Companies 364

Pharma Companies Marketing Drugs 364

pharmaphorum

OCTOBER 8, 2024

How pharma companies can build mutually beneficial relationships with biotech and digital health start-ups Mike.Hammerton Tue, 08/10/2024 - 10:59 Bookmark this

Pharma Companies 117

Pharma Companies 117

Bio Pharma Dive

OCTOBER 1, 2024

Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies' research progress. Here’s a list of conferences to watch in 2025.

Pharma Companies 307

Pharma Companies Clinical Trials Clinical Trials Trials 307

Bio Pharma Dive

JANUARY 5, 2022

The pharma company, already partnered with BioNTech on vaccines for COVID-19 and influenza, will pay $225 million upfront to further expand its work with the German biotech.

Vaccine 334

Vaccine Vaccination Pharma Companies 334

Bio Pharma Dive

DECEMBER 10, 2021

The collaboration with Regor Therapeutics is another example of large pharma companies' interest in partnering with emerging biotechs from China.

Pharma Companies 321

Pharma Companies Research 321

Bio Pharma Dive

NOVEMBER 28, 2023

tax law changes enacted six years ago slashed large pharma companies' rates and saved them billions. Now, a push for an international floor could disrupt their R&D accounting.

Pharma Companies 317

Pharma Companies 317

Bio Pharma Dive

SEPTEMBER 2, 2021

The pharma company is in a tight race with rivals, including GSK, to become the first with an approved shot for the infectious disease.

Pharma Companies 306

Pharma Companies Vaccine Vaccination Research 306

Pharmaceutical Technology

APRIL 16, 2024

The price ceiling policy has been in place for more than 20 years, but it has neither been very successful nor free of consequences for pharma companies.

Pharma Companies 278

Pharma Companies Marketing 278

Bio Pharma Dive

MARCH 1, 2023

The pharma company, along with its diabetes drug rivals Novo Nordisk and Sanofi, has long been under pressure over the high cost of insulin — scrutiny that has recently ramped up in the U.S.

Insulin 290

Insulin Pharma Companies Drugs 290

Bio Pharma Dive

JUNE 2, 2022

Severino left the pharma company in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup.

Pharma Companies 278

Pharma Companies Genetics Scientist Medicine 278

Pharma Times

AUGUST 19, 2024

The contract concerns profiling Immunoglobulin E autoantibodies in blood serum

Pharma Companies 119

Pharma Companies Medicine 119

Pharmaceutical Technology

NOVEMBER 20, 2024

Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scientific exchange between clinical experts and pharmaceutical companies.

Pharma Companies 130

Pharma Companies 130

Bio Pharma Dive

NOVEMBER 14, 2022

Normalized lab data can help pharma companies promote their therapies to a targeted audience.

Pharma Companies 246

Pharma Companies 246

Pharmaceutical Technology

AUGUST 18, 2023

Competitive intelligence is a vital tool of the research and analysis toolbox for firms wanting valuable data on their market, competitors and customers

Pharma Companies 130

Pharma Companies Marketing Research 130

Bio Pharma Dive

OCTOBER 9, 2024

Many pharma companies are now using de-identified lab data to identify potential patients and their physicians in time to impact the patient’s treatment plan. In this Q&A, learn how lab data can be used to increase patient access.

Pharma Companies 246

Pharma Companies 246

Bio Pharma Dive

NOVEMBER 13, 2020

An alliance with BeyondSpring spinout Seed Therapeutics makes Eli Lilly the latest pharma company to dive into the fast-emerging drug research field.

Protein 243

Protein Pharma Companies Drugs Research 243

Bio Pharma Dive

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies 246

Pharma Companies Research Medicine Drugs 246

Bio Pharma Dive

AUGUST 26, 2022

The pharma company terminated a collaboration that could’ve netted the biotech about $350 million. It’s the latest in a string of recent setbacks for microbiome drug developers.

Pharma Companies 242

Pharma Companies Drugs Development 242

pharmaphorum

JUNE 10, 2024

Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.

Pharma Companies 118

Pharma Companies 118

World of DTC Marketing

JANUARY 11, 2022

Further, 62% of HCPs said that the most significant area where pharma representatives can add value is, by understanding the needs of HCPs and sharing only relevant content with them to make the interactions more insightful. At the same time, marketing emails are among the top 5 channels used by pharma companies to engage HCPs.

Pharma Companies 235

Pharma Companies Sales Marketing Clinical Trials 235

Pharmaceutical Technology

OCTOBER 28, 2022

Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins. This helps to reduce human error and provide more reliable, replicable results and increase the speed of drug discovery and development processes.

Development 311

Development Drugs Pharma Companies Life Science 311

Pharmaceutical Technology

MAY 7, 2024

The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.

Pharma Companies 195

Pharma Companies 195

Bio Pharma Dive

JUNE 16, 2022

The German pharma company has secured an option to acquire Trutino Biosciences, two years after inking a research collaboration with the San Diego drug developer.

Pharma Companies 219

Pharma Companies Development Drugs Research 219

Bio Pharma Dive

FEBRUARY 17, 2022

The agreement with the Cambridge-based startup is the latest to reflect growing large pharma company interest in targeting RNA with small molecules.

RNA 204

RNA Pharma Companies Research 204

Bio Pharma Dive

DECEMBER 12, 2023

The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.

Vaccine 200

Vaccine Vaccination Pharma Companies Development 200

Bio Pharma Dive

MARCH 15, 2023

Under the Inflation Reduction Act, pharma companies owe rebates to Medicare for price increases that exceed inflation. But they won’t need to pay until 2025.

Pharma Companies 200

Pharma Companies Drugs 200

Outsourcing Pharma

JUNE 27, 2024

The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.

Pharma Companies 89

Pharma Companies Regulation Marketing 89

Pharmaceutical Technology

JANUARY 16, 2023

In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration. Moreover, Insilico Medicine’s INS018_055, an AI-designed candidate, has produced positive topline results in its Phase I clinical trial for idiopathic pulmonary fibrosis (IPF) treatment.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

Bio Pharma Dive

APRIL 7, 2022

The pharma company adds experimental RSV treatments to its pipeline through the deal, which is worth up to $525 million.

Pharma Companies 189

Pharma Companies Research Drugs 189

Bio Pharma Dive

OCTOBER 28, 2022

Disappointing study results have led the French pharma company to take a $1.6 billion impairment charge and plan new early-stage trials for a drug executives once called a potential “foundation” for newer immunotherapy combinations.

Pharma Companies 200

Pharma Companies Drugs Trials 200

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 17, 2024

The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.

Pharma Companies 187

Pharma Companies Branding Marketing Clinical Trials 187

Bio Pharma Dive

JULY 29, 2024

The pharma company will pay up to $1.3 billion to acquire San Diego-based Nerio and its research into novel immune checkpoint inhibitors.

Pharma Companies 162

Pharma Companies Drugs Research 162